Uso de antibióticos en un hospital general de agudos

Objective: To know the number of hospitalized patients with antibiotics in one day and to evaluate the rationality of its indication. Methods: Crossover study in two single days. Results: We included 230 patients who received antibiotics (39.8% of all hospitalized patients). The indication was to...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Revista Médica Universitaria
Autores principales: Acosta, Silvia Patricia, Attorri, Silvia, Carena, José Alberto, Prieto, S., Salomón, Susana Elsa, Torres, A.
Materias:
Acceso en línea:https://bdigital.uncu.edu.ar/fichas.php?idobjeto=8518
Descripción
Sumario:Objective: To know the number of hospitalized patients with antibiotics in one day and to evaluate the rationality of its indication. Methods: Crossover study in two single days. Results: We included 230 patients who received antibiotics (39.8% of all hospitalized patients). The indication was to prophylaxis in 42.6% and to infection treatment in 57.4% of the cases. The last one indication was in clinically documented infection in 75.8%, bacteriologicaly documented in 24.2% and nosocomial acquired in 23.5%. The antibiotics more used were ß-Lactams (80.4%) and 36.1% received more than one. In the 97.4% and in 94.8% the prescribing physician knew that the patient was on ATB therapy and the reason of indication. The dose and the route of administration was correct in 92.2% and 97.8% respectively. The 73% of all physicians knew at least one adverse effect and 19% of them could say three. The 23.5% of them knew the cost of the prescribed ATB. We did not find differences in the two compared seasons except in the second period where the physicians mentioned three adverse effects (9.8 vs 25.3%) (p<0.05). Conclusions: The 39.8% of all hospitalized patients received antibiotics and in only 24.2% of the cases the infections were bacteriologicaly documented. Most of the physicians knew that their patient was on antibiotics therapy, the reason of indication, the main adverse effects but not the cost of them.